Recurrent Childhood Acute Lymphoblastic Leukemia Active Not Recruiting Phase 1 / 2 Trials for DB00493 (Cefotaxime)

IndicationStatusPhase
DBCOND0028597 (Recurrent Childhood Acute Lymphoblastic Leukemia)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs